Literature DB >> 24814140

Negative symptoms and everyday functioning in schizophrenia: a cross-sectional study in a real world-setting.

Paola Rocca1, Cristiana Montemagni2, Serena Zappia2, Rosellina Piterà3, Monica Sigaudo2, Filippo Bogetto2.   

Abstract

Negative symptoms have been suggested to have a greater impact on real-world functioning in schizophrenia than other symptoms. We aimed to examine the relationship of specific negative symptoms components ("expressive deficits" - DE - which include alogia and blunted affect, and "avolition" - AA - which includes amotivation, anhedonia, and asociality), with separate domains of real-world outcomes (the Personal and Social Performance Scale - PSP - and selected items of the Heinrichs Quality of Life Scale - QLS - that did not overlap with negative symptoms) and two functional milestones (recent employment and marriage). Regression analyses were performed to identify the determinants of QLS and PSP scores and of the two milestones, in 92 consecutive outpatients with stable schizophrenia. AA was the strongest predictor of QLS interpersonal relations and social network (IRSN), PSP total score and the first three PSP domains. The variance explained ranged from 36% for PSP self care to 54% for the PSP personal and social relationships. Moreover, higher scores in AA were significant predictors of the single status. DE does not appear to have an impact at real-world functional performance. Taken together, our analysis indicates a relatively specific set of relationships between the AA subdomain and aspects of real-world functioning in schizophrenia. These findings, if confirmed, could have important implications for research, diagnostics and treatment: in fact our results would suggest that AA and DE should be analyzed as separate and distinct domains to be rated and treated individually.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Avolition; Expressive deficits; Functional milestones; Real-world functioning

Mesh:

Year:  2014        PMID: 24814140     DOI: 10.1016/j.psychres.2014.04.018

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  14 in total

Review 1.  Treatment resistant schizophrenia: Clinical, biological, and therapeutic perspectives.

Authors:  Frederick C Nucifora; Edgar Woznica; Brian J Lee; Nicola Cascella; Akira Sawa
Journal:  Neurobiol Dis       Date:  2018-08-29       Impact factor: 5.996

2.  The Important Role of Motivation and Pleasure Deficits on Social Functioning in Patients With Schizophrenia: A Network Analysis.

Authors:  Hui-Xin Hu; Wilson Y S Lau; Eugenia P Y Ma; Karen S Y Hung; Si-Yu Chen; Kin-Shing Cheng; Eric F C Cheung; Simon S Y Lui; Raymond C K Chan
Journal:  Schizophr Bull       Date:  2022-06-21       Impact factor: 7.348

3.  Systematic review of global functioning and quality of life in people with psychotic disorders.

Authors:  A G Nevarez-Flores; K Sanderson; M Breslin; V J Carr; V A Morgan; A L Neil
Journal:  Epidemiol Psychiatr Sci       Date:  2018-10-01       Impact factor: 6.892

4.  Social affiliation and negative symptoms in schizophrenia: Examining the role of behavioral skills and subjective responding.

Authors:  Jack J Blanchard; Stephanie G Park; Lauren T Catalano; Melanie E Bennett
Journal:  Schizophr Res       Date:  2015-07-31       Impact factor: 4.939

5.  The Relationship of Motivation and Neurocognition with Functionality in Schizophrenia: A Meta-analytic Review.

Authors:  Antonia Najas-Garcia; Juana Gómez-Benito; Tania B Huedo-Medina
Journal:  Community Ment Health J       Date:  2018-03-31

6.  The Role of Cytokines in Predicting the Efficacy of Acute Stage Treatment in Patients with Schizophrenia.

Authors:  Xiaoyan He; Qingyan Ma; Yajuan Fan; Binbin Zhao; Wei Wang; Feng Zhu; Xiancang Ma; Lina Zhou
Journal:  Neuropsychiatr Dis Treat       Date:  2020-01-21       Impact factor: 2.570

7.  A Two-Factor Model Better Explains Heterogeneity in Negative Symptoms: Evidence from the Positive and Negative Syndrome Scale.

Authors:  Seon-Kyeong Jang; Hye-Im Choi; Soohyun Park; Eunju Jaekal; Ga-Young Lee; Young Il Cho; Kee-Hong Choi
Journal:  Front Psychol       Date:  2016-05-12

8.  Confirmatory Factor Analysis and Differential Relationships of the Two Subdomains of Negative Symptoms in Chronically Ill Psychotic Patients.

Authors:  Annemarie P M Stiekema; Edith J Liemburg; Lisette van der Meer; Stynke Castelein; Roy Stewart; Jaap van Weeghel; André Aleman; Richard Bruggeman
Journal:  PLoS One       Date:  2016-02-19       Impact factor: 3.240

9.  Behavioral outputs of negative symptom domains of schizophrenia.

Authors:  Octavia Căpățînă; Mihaela Fadgyas Stănculete; Ioana Micluția
Journal:  Exp Ther Med       Date:  2021-05-26       Impact factor: 2.447

10.  Psychosocial functioning in schizophrenia: are some symptoms or demographic characteristics predictors across the functioning domains?

Authors:  Sirijit Suttajit; Suwanna Arunpongpaisal; Manit Srisurapanont; Nuntika Thavichachart; Ronnachai Kongsakon; Sunanta Chantakarn; Vasu Chantarasak; Apichat Jariyavilas; Piyadit Jaroensook; Khanogwan Kittiwattanagul; Osot Nerapusee
Journal:  Neuropsychiatr Dis Treat       Date:  2015-09-29       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.